The Nanomedicine Award was set up by the European Technology Platform for Nanomedicine (ETPN) and the EU funded consortium NANOMED2020, to honour the best international nanomedicine innovations. Entrants from academia and industry are eligible for the award, which covers the fields of diagnostics and imaging, therapeutics and regenerative medicine.
“Endomagnetics is very honoured to have been selected for an inaugural Nanomedicine Award, particularly given the global candidature and great promise of this convergent industry,” said the company’s CEO Eric Mayes. “This award enhances the medtech facet of nanomedicine and increases the visibility of our SentiMag and Sienna systems to potential partners as we develop further across the nanomedicine field.”
Receive the Funding Newswire each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening. 
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.